Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

Shots:

• Medtronic reports that it has secured for its reimbursement for the MiniMed 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The reimbursement agreement will be effective from Aug 29, 2019
• The granted reimbursement will increase the accessibility of Medtronic’s MiniMed 670G Insulin pump system to more patients with type 1 diabetes
• MiniMed 670G is the only commercially available technology that personalizes the delivery of basal insulin 24hrs. a day based on real-time insulin needs, maximizing Time in Range in patients with T1D

Click here to­ read full press release/ article | Ref: Medtronic | Image: Integrated Diabetes Services